^
Association details:
Biomarker:No biomarker
Cancer:Peritoneal Cancer
Drug:oxaliplatin (DNA synthesis inhibitor, DNA cross linking agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Acceptable Recurrence Therapies for…Peritoneal Cancer: Other Recommended Regimen...Oxaliplatin